Growth Hormone Deficiency Clinical Trials

173 clinical trials for Growth Hormone Deficiency across international registries, including 19 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency — RECRUITING · PHASE3
• Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature — RECRUITING
• GB06 Phase III Trial for Pediatric Growth Hormone Deficiency — RECRUITING · PHASE3
• A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA — RECRUITING
• A Study to Follow Paediatric Participants With Growth Hormone Deficiency Treated With Somapacitan for Long Term Safety Information and Clinical Parameters — RECRUITING
• Effects of GH and Lirglutide on AgRP — RECRUITING · PHASE4
• REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD) — RECRUITING · NA
• A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin — RECRUITING
• Chromosome 18 Clinical Research Center — RECRUITING
• Evaluation of the Propensity of Patients Under rhGH to Envision a Modification of Their Treatment Regimen Toward LAGH — RECRUITING · NA
• A Long-Term Safety Trial of LUM-201 in Children With Idiopathic Growth Hormone Deficiency Who Have Previously Completed a LUM-201 Clinical Trial (OraGrowtH211) — RECRUITING · PHASE2
• Growth Hormone Replacement Therapy for Retried Professional Football Players — RECRUITING · PHASE2
• A MULTICENTER, OPEN-LABEL, EXTENSION TRIAL TO INVESTIGATE LONG TERM EFFICACY AND SAFETY OF LONAPEGSOMATROPIN IN ADULTS WITH GROWTH HORMONE DEFICIENCY — RECRUITING
• FORESIGHT: A MULTICENTER, RANDOMIZED, PARALLEL-ARM, PLACEBO-CONTROLLED (DOUBLE-BLIND) AND ACTIVE-CONTROLLED (OPEN-LABEL) TRIAL TO COMPARE THE EFFICACY AND SAFETY OF ONCE-WEEKLY LONAPEGSOMATROPIN WITH PLACEBO AND A DAILY SOMATROPIN PRODUCT IN ADULTS WITH GROWTH HORMONE DEFICIENCY — RECRUITING
• Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA , ISS and PWS in Children — RECRUITING
• A TRIAL COMPARING THE EFFECT AND SAFETY OF ONCE WEEKLY DOSING OF SOMAPACITAN WITH DAILY NORDITROPIN® IN CHILDREN WITH GROWTH HORMONE DEFICIENCY. — RECRUITING
• A MULTICENTER, PHASE 3, OPEN-LABEL, 26-WEEK TRIAL INVESTIGATING THE SAFETY, TOLERABILITY AND EFFICACY OF TRANSCON HGH ADMINISTERED ONCE WEEKLY IN CHILDREN WITH GROWTH HORMONE DEFICIENCY (GHD) — RECRUITING · PHASE3
• A PHASE 3, OPEN-LABEL, RANDOMIZED, MULTICENTER, 12 MONTHS, EFFICACY AND SAFETY STUDY OF WEEKLY MOD-4023 COMPARED TO DAILY GENOTROPIN THERAPY IN PRE-PUBERTAL CHILDREN WITH GROWTH HORMONE DEFICIENCY — RECRUITING · PHASE3
• COMPARISON OF VRS-317, A LONG-ACTING HUMAN GROWTH HORMONE, TO DAILY RHGH IN A PHASE 3, RANDOMIZED, ONE-YEAR, OPEN-LABEL, MULTICENTER, NON-INFERIORITY TRIAL IN PRE-PUBERTAL CHILDREN WITH GROWTH HORMONE DEFICIENC — RECRUITING · PHASE3
• To investigate the effect of different doses of Growth Hormone treatment on the risk of developing cardiovascular diseases in patients with growth hormone deficiency — ACTIVE_NOT_RECRUITING · PHASE4
• A Phase 2, Multiple Dose, Open-Label, Parallel-Group, Active Controlled, Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ACP-001 in Adult Patients with Growth Hormone Deficiency (AGHD) — COMPLETED · PHASE2
• Phase 3 Long Term Safety Extension Study of LUM-201 in Children With Growth Hormone Deficiency — NOT_YET_RECRUITING · PHASE3
• Safety, PK/PD (Pharmacokinetics/Pharmacodynamics) and Efficacy of ACP-001 Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD) — COMPLETED · PHASE2
• A Trial to Compare the Efficacy and Safety of Once-weekly Lonapegsomatropin With Placebo and a Daily Somatropin Product in Adults With Growth Hormone Deficiency — COMPLETED · PHASE3
• Phase 2 Study of LUM-201 in Children With Growth Hormone Deficiency (OraGrowtH210 Trial) — COMPLETED · PHASE2
• Body Composition and Adipose Tissue in HIV — TERMINATED · PHASE4
• Phase 2 Study of LUM-201 in Children Who Have Previously Completed the LUM-201-01 Trial (OraGrowtH213) — COMPLETED · PHASE2
• Evaluation of (Cardio)Metabolic and Auxological Outcomes of GHD Patients Under rhGH or LAGH With Stratification According to IGF-1 Levels — NOT_YET_RECRUITING · NA
• A Study to Learn How Different Injector Pens Affect the Study Medicine Called Genotropin® (somatropin) Delivery and Taken Up Into the Blood in Healthy Adults — OTHER · PHASE1
• A Multicenter, 12-Month, Randomized, Double Blind, Placebo-Controlled Phase 3 Efficacy and Safety Study of Daily Oral LUM 201 in Naïve-to-Treatment, Prepubertal Children with Growth Hormone Deficiency (GHD) — OTHER · PHASE3
• Hypothalamic-Stratified Nursing Pathway for Pediatric Craniopharyngioma — COMPLETED
• Growth and Asymmetric diMethylArginine — COMPLETED
• Development of a Personalized Growth Hormone Treatment Profile (PGTP) Report for Pediatric Endocrinology — COMPLETED
• Skeletal Muscle Effects of GH in Boys — COMPLETED
• Biological Age in Children With GH Deficiency Undergoing Hormone Replacement Therapy — COMPLETED
• The AgRP and GH/IGF-1 Axis in Children — NOT_YET_RECRUITING
• Evaluating the Efficacy and Safety of GB08 Injection in Pediatric Patients With Growth Hormone Deficiency — NOT_YET_RECRUITING · PHASE2
• Adipose Tissue and Serum Inflammation in GH Deficiency — COMPLETED
• Adipose Tissue and Circulating Markers of Inflammation in GH Deficiency and Changes With GH Therapy — COMPLETED
• Long Term Follow up Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children — COMPLETED · PHASE2
• Development and Validation of a Self-assessment System Based on a Mobile App to Manage Adult Growth Hormone Deficiency — COMPLETED · NA
• Effects of Growth Hormone (GH) Deficiency and Growth Hormone Replacement on Serum Fibroblast Growth Factor 21 (FGF21) — WITHDRAWN
• BELux Children OutcoME During A(@)Dulthood With GHD — NOT_YET_RECRUITING · NA
• Assessment of Adherence, Quality of Life, Clinical Response and Safety of Daily and Long-Acting Growth Hormone Therapy — COMPLETED
• A Research Study of How Well Macimorelin Works to Find Out if Children Have a Lack of Growth Hormone and How Safe it is — COMPLETED · PHASE3
• Differential Effects of rhGH vs. rhIGF-1 on Cardiovascular Risk Factors — TERMINATED · PHASE1
• Use of miRNAs in Growth Hormone Deficiency (GHD) — OTHER
• Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm — COMPLETED · PHASE3
• Safety and Efficacy of Y-shape Pegylated Somatropin in Growth Hormone Deficiency Children — COMPLETED · PHASE2
• Dynamic Hormone Diagnostics in Endocrine Disease — COMPLETED

Refine this search